![Constitutional POLE variants causing a phenotype reminiscent of constitutional mismatch repair deficiency - Sehested - 2022 - Human Mutation - Wiley Online Library Constitutional POLE variants causing a phenotype reminiscent of constitutional mismatch repair deficiency - Sehested - 2022 - Human Mutation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7694b187-ec8c-46b1-a45d-348fc21e5643/humu24299-gra-0001-m.jpg?trick=1698226405839)
Constitutional POLE variants causing a phenotype reminiscent of constitutional mismatch repair deficiency - Sehested - 2022 - Human Mutation - Wiley Online Library
![Genes | Free Full-Text | Risks at the DNA Replication Fork: Effects upon Carcinogenesis and Tumor Heterogeneity Genes | Free Full-Text | Risks at the DNA Replication Fork: Effects upon Carcinogenesis and Tumor Heterogeneity](https://pub.mdpi-res.com/genes/genes-08-00046/article_deploy/html/images/genes-08-00046-g001.png?1569190559)
Genes | Free Full-Text | Risks at the DNA Replication Fork: Effects upon Carcinogenesis and Tumor Heterogeneity
![ESMO Virtual Congress 2020: High Activity of Nivolumab in Patients with Pathogenic Exonucleasic Domain POLE (edPOLE) Mutated Mismatch Repair Proficient Advanced Tumours ESMO Virtual Congress 2020: High Activity of Nivolumab in Patients with Pathogenic Exonucleasic Domain POLE (edPOLE) Mutated Mismatch Repair Proficient Advanced Tumours](https://www.urotoday.com/images/ESMO_POLE_gene.png)
ESMO Virtual Congress 2020: High Activity of Nivolumab in Patients with Pathogenic Exonucleasic Domain POLE (edPOLE) Mutated Mismatch Repair Proficient Advanced Tumours
![The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management | Familial Cancer The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management | Familial Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10689-021-00256-y/MediaObjects/10689_2021_256_Fig3_HTML.png)
The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management | Familial Cancer
![Novel POLE mutations identified in patients with IMAGE-I syndrome cause aberrant subcellular localisation and protein degradation in the nucleus | Journal of Medical Genetics Novel POLE mutations identified in patients with IMAGE-I syndrome cause aberrant subcellular localisation and protein degradation in the nucleus | Journal of Medical Genetics](https://jmg.bmj.com/content/jmedgenet/59/11/1116/F1.large.jpg)
Novel POLE mutations identified in patients with IMAGE-I syndrome cause aberrant subcellular localisation and protein degradation in the nucleus | Journal of Medical Genetics
![Frontiers | Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma Frontiers | Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma](https://www.frontiersin.org/files/Articles/751977/fgene-12-751977-HTML/image_m/fgene-12-751977-g004.jpg)
Frontiers | Protumorigenic Role of Elevated Levels of DNA Polymerase Epsilon Predicts an Immune-Suppressive Microenvironment in Clear Cell Renal Cell Carcinoma
![Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer | bioRxiv Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2019/06/24/681767/F1.large.jpg)
Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer | bioRxiv
![Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population | Scientific Reports Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-019-52414-z/MediaObjects/41598_2019_52414_Fig1_HTML.png)
Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population | Scientific Reports
![Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study - The Lancet Gastroenterology & Hepatology Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/becf9dd4-7e01-4863-a17f-2c29901e741a/gr1.gif)
Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study - The Lancet Gastroenterology & Hepatology
![POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02422-1/MediaObjects/13046_2022_2422_Fig2_HTML.png)
POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
![Frontiers | Analysis of Mutations and Dysregulated Pathways Unravels Carcinogenic Effect and Clinical Actionability of Mutational Processes Frontiers | Analysis of Mutations and Dysregulated Pathways Unravels Carcinogenic Effect and Clinical Actionability of Mutational Processes](https://www.frontiersin.org/files/Articles/768981/fcell-09-768981-HTML/image_m/fcell-09-768981-g001.jpg)
Frontiers | Analysis of Mutations and Dysregulated Pathways Unravels Carcinogenic Effect and Clinical Actionability of Mutational Processes
Mutations in the POLE exonuclease domain in ECs. (A) Mutations in the... | Download Scientific Diagram
![Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations | Scientific Reports Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-26967-4/MediaObjects/41598_2018_26967_Fig1_HTML.jpg)
Molecular profiling and sequential somatic mutation shift in hypermutator tumours harbouring POLE mutations | Scientific Reports
![Pathogenic, somatic POLE mutations in precursors of endometrial and... | Download Scientific Diagram Pathogenic, somatic POLE mutations in precursors of endometrial and... | Download Scientific Diagram](https://www.researchgate.net/publication/339722955/figure/fig1/AS:865756896055298@1583423937641/Pathogenic-somatic-POLE-mutations-in-precursors-of-endometrial-and-colorectal-cancers.png)
Pathogenic, somatic POLE mutations in precursors of endometrial and... | Download Scientific Diagram
Mutational processes of distinct POLE exonuclease domain mutants drive an enrichment of a specific TP53 mutation in colorectal cancer | PLOS Genetics
![Explosive mutation accumulation triggered by heterozygous human Pol ε proofreading-deficiency is driven by suppression of mismatch repair | eLife Explosive mutation accumulation triggered by heterozygous human Pol ε proofreading-deficiency is driven by suppression of mismatch repair | eLife](https://iiif.elifesciences.org/lax/32692%2Felife-32692-fig5-v1.tif/full/1500,/0/default.jpg)
Explosive mutation accumulation triggered by heterozygous human Pol ε proofreading-deficiency is driven by suppression of mismatch repair | eLife
![POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02422-1/MediaObjects/13046_2022_2422_Fig1_HTML.png)
POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text
![Cancers | Free Full-Text | Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy Cancers | Free Full-Text | Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy](https://www.mdpi.com/cancers/cancers-13-02487/article_deploy/html/images/cancers-13-02487-g001.png)
Cancers | Free Full-Text | Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
![Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan | SpringerLink Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00795-020-00273-3/MediaObjects/795_2020_273_Fig1_HTML.png)
Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan | SpringerLink
![High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation | Modern Pathology High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41379-019-0430-6/MediaObjects/41379_2019_430_Fig1_HTML.png)